All patients on aspirin or warfarin were once advised to stop taking these anticoagulants two weeks before surgery. But new evidence shows that many patients suffer serious thrombotic events as a result, underscoring the need for a more measured approach. In today’s discussion, Dr. Yoash Enzer, clinical associate professor at Brown University, offers practical advice on how to balance the risk of bleeding with the risk of thromboembolism.

Financial Disclosures: Dr. Enzer and Dr. Goldberg have no financial disclosures to report.